Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Johan Neyts and Steven De Jonghe.
Johan Neyts
Connection Strength
0.776
Steven De Jonghe
  1. Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model. J Infect Dis. 2021 09 01; 224(5):749-753.
    View in: PubMed
    Score: 0.241
  2. Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues. Antiviral Res. 2021 09; 193:105127.
    View in: PubMed
    Score: 0.238
  3. Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase. Antiviral Res. 2021 09; 193:105142.
    View in: PubMed
    Score: 0.060
  4. In vitro activity of itraconazole against SARS-CoV-2. J Med Virol. 2021 Jul; 93(7):4454-4460.
    View in: PubMed
    Score: 0.060
  5. A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents. Antiviral Res. 2021 08; 192:105122.
    View in: PubMed
    Score: 0.060
  6. 1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors. Eur J Med Chem. 2021 Oct 05; 221:113494.
    View in: PubMed
    Score: 0.059
  7. Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19. J Phys Chem Lett. 2021 Feb 25; 12(7):1793-1802.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.